Literature DB >> 17722665

Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study.

Imoigele P Aisiku1, Lynne T Penberthy, Wally R Smith, Viktor E Bovbjerg, Donna K McClish, James L Levenson, John D Roberts, Susan D Roseff.   

Abstract

BACKGROUND: Sickle cell disease (SCD) patients can receive their ambulatory care from either SCD specialists (caregivers with sickle cell-only clinics) or nonspecialized care centers. Patient satisfaction, an important factor that may influence compliance and outcome, can differ between the two groups because of the perceived quality of care, outcomes or practice style.
METHODS: We administered a patient satisfaction survey to 308 participants in an SCD prospective cohort study. Of the 308 patients, 133 (43.2%) received the majority of their SCD care at specialized centers, 152 (49.3%) received their care from nonspecialized centers and 26 (7.5) did not provide information. The satisfaction surveys measured general satisfaction (GS), technical quality (TQ), interpersonal manner (IM), communication (CM), financial aspects (FA), time spent with doctor (TA), and accessibility and convenience (AC). Patients reported their levels of satisfaction using a five-point Likert scale. We compared unadjusted group means, as well as means adjusted for potential confounders such as marital status, on patient satisfaction between specialized and nonspecialized centers.
RESULTS: SCD patients who received their care from specialized centers had significantly higher mean satisfaction scores, compared to those who received their care from nonspecialized centers: GS 4.00(+/-0.93) vs. 3.66 (+/- 01.16, p=0.0326), TQ 3.98 (+/- 0.77) vs. 3.65 (+/- 0.91, p=0.0058), AC 3.83 (+/-0.79) vs. 3.51 (+/- 1.02, p=0.0142) , FA 3.88 (+/-0.96) vs. 3.49 (+/-1.25, p=0.0120). There were no statistically significant group differences in IM, TA and CM.
CONCLUSION: SCD patients who received most of their SCD care from specialized centers had somewhat higher satisfaction scores in some areas when compared with patients who received their care from nonspecialized centers.

Entities:  

Mesh:

Year:  2007        PMID: 17722665      PMCID: PMC2574305     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  25 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Taking action on the volume-quality relationship: how long can we hide our heads in the colostomy bag?

Authors:  Thomas J Smith; Bruce E Hillner; Harry D Bear
Journal:  J Natl Cancer Inst       Date:  2003-05-21       Impact factor: 13.506

3.  Selective referral to high-volume hospitals: estimating potentially avoidable deaths.

Authors:  R A Dudley; K L Johansen; R Brand; D J Rennie; A Milstein
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

Review 4.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

Review 5.  Sickle-cell disease.

Authors:  G R Serjeant
Journal:  Lancet       Date:  1997-09-06       Impact factor: 79.321

6.  Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.

Authors:  K L O'Brien; A J Swift; J A Winkelstein; M Santosham; B Stover; R Luddy; J E Gootenberg; J T Nold; A Eskenazi; S J Snader; H M Lederman
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

Review 7.  Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways.

Authors:  T J Smith; B E Hillner
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

8.  Pain management and symptoms of substance dependence among patients with sickle cell disease.

Authors:  James Elander; Joanne Lusher; David Bevan; Paul Telfer
Journal:  Soc Sci Med       Date:  2003-11       Impact factor: 4.634

Review 9.  Sickle cell anaemia: epidemiology and cost of illness.

Authors:  Paul J Nietert; Marc D Silverstein; Miguel R Abboud
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 10.  The comprehensiveness care of sickle cell disease.

Authors:  Iheanyi Okpala; Veronica Thomas; Neil Westerdale; Tina Jegede; Kavita Raj; Sadie Daley; Hilda Costello-Binger; Jean Mullen; Collis Rochester-Peart; Sarah Helps; Emense Tulloch; Mary Akpala; Moira Dick; Susan Bewley; Mark Davies; Ian Abbs
Journal:  Eur J Haematol       Date:  2002-03       Impact factor: 2.997

View more
  8 in total

Review 1.  Systems-based hematology: highlighting successes and next steps.

Authors:  Jori E May; Patrick C Irelan; Kailee Boedeker; Emily Cahill; Steven Fein; David A Garcia; Lisa K Hicks; Janice Lawson; Ming Y Lim; Colleen T Morton; Anita Rajasekhar; Satish Shanbhag; Marc S Zumberg; Robert M Plovnick; Nathan T Connell
Journal:  Blood Adv       Date:  2020-09-22

2.  Concentration of hospital care for acute sickle cell disease-related visits.

Authors:  J A Panepinto; P L Owens; A L Mosso; C A Steiner; D C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

3.  Experiences of Pediatric Patients With Sickle Cell Disease in Rural Emergency Departments.

Authors:  Kristen J Alston; Cecelia R Valrie; Christy Walcott; Tamara D Warner; Beng Fuh
Journal:  J Pediatr Hematol Oncol       Date:  2015-04       Impact factor: 1.289

4.  Satisfied or not satisfied: pain experiences of patients with sickle cell disease.

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Marie L Suarez; Yingwei Yao; Diana J Wilkie
Journal:  J Adv Nurs       Date:  2015-04-27       Impact factor: 3.187

5.  An unequal burden: poor patient-provider communication and sickle cell disease.

Authors:  Carlton Haywood; Shawn Bediako; Sophie Lanzkron; Marie Diener-West; John Strouse; Jennifer Haythornthwaite; Gladys Onojobi; Mary Catherine Beach
Journal:  Patient Educ Couns       Date:  2014-05-23

6.  Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico.

Authors:  Diana V Rodríguez-Rivera; Yerania Rodríguez-Navedo; Mariely Nieves-Plaza; Luis M Vilá
Journal:  SAGE Open Med       Date:  2016-09-23

7.  Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals' views.

Authors:  Maite E Houwing; Marit Buddenbaum; Thijs C J Verheul; Anne P J de Pagter; Jacobus N J Philipsen; Jan A Hazelzet; Marjon H Cnossen
Journal:  BMC Health Serv Res       Date:  2021-03-12       Impact factor: 2.655

8.  Effects of Music Therapy on Quality of Life in Adults with Sickle Cell Disease (MUSIQOLS): A Mixed Methods Feasibility Study.

Authors:  Samuel N Rodgers-Melnick; Lucas Lin; Kristina Gam; Evanilda Souza de Santana Carvalho; Coretta Jenerette; Douglas Y Rowland; Jane A Little; Jeffery A Dusek; Nitya Bakshi; Lakshmanan Krishnamurti
Journal:  J Pain Res       Date:  2022-01-11       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.